Previously submitted to: JMIR Medical Informatics (no longer under consideration since Sep 29, 2026)
Date Submitted: Sep 28, 2026
Open Peer Review Period: Sep 29, 2026 - Sep 29, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Acupuncture Clinical Trial Registration for Vertigo: A Multi-Registry Cross-Sectional Analysis (ClinicalTrials.gov, ChiCTR, and ITMCTR, 2007–2026)
ABSTRACT
Background:
Vertigo is among the most common clinical complaints, and acupuncture is widely investigated as a non-pharmacological treatment. The acupuncture-vertigo evidence base has not, however, been characterized at the trial registration level, and no prior multi-registry analysis for this indication has included ITMCTR.
Objective:
To conduct a cross-sectional analysis of acupuncture clinical trial registrations across ClinicalTrials.gov, ChiCTR, and ITMCTR, integrating natural language processing-based screening and classification to characterize trial characteristics, intervention profiles, and registration completeness.
Methods:
We searched ClinicalTrials.gov (API v2), ChiCTR, and ITMCTR (web interfaces) using vertigo- and acupuncture-related terms. Keyword-based classification and entity extraction identified acupuncture-vertigo studies; rule-based named entity recognition captured acupoints, methods, controls, subtypes, and outcomes. Joinpoint Poisson regression characterized temporal trends, and an eight-item rubric adapted from the WHO Trial Registration Data Set scored registration completeness.
Results:
Overall, 3,520 vertigo-related trial records were retrieved (3,448 from ClinicalTrials.gov, 51 from ChiCTR, 21 from ITMCTR), yielding 55 confirmed acupuncture-vertigo trials: 29 on ClinicalTrials.gov (0.84%), 15 on ChiCTR (29.4%), and 11 on ITMCTR (52.4%). Registration density was approximately 35-fold higher in ChiCTR and 62-fold higher in ITMCTR than in ClinicalTrials.gov. Disease spectrum differed markedly: cervical vertigo predominated on the Chinese registries (ChiCTR, 40.0%) but was absent from ClinicalTrials.gov. Blinding was not stated in 27–73% of trials across registries. Registration completeness on ClinicalTrials.gov averaged 5.93 of 8 and declined significantly over two decades (β = -0.0158/year, P < .001).
Conclusions:
Acupuncture clinical trial registration for vertigo is concentrated in Chinese registries by density, yet ClinicalTrials.gov contributes nearly all internationally accessible structured data. Registry-dependent disease spectra and persistent non-reporting of blinding status underscore the need for multi-registry surveillance and standardized, etiology-specific registration as minimum conditions for evidence synthesis. Clinical Trial: N/A. This study is a secondary cross-sectional analysis of publicly available, de-identified clinical trial registry records (ClinicalTrials.gov, ChiCTR, and ITMCTR). It did not involve human participants and therefore did not require prospective trial registration.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.